BUSCADOR RECOLECTA

Objectives: To identify, critically appraise, and synthesize the available evidence on the effectiveness of digital
health interventions to improve the quality of life or any of its four dimensions (physical, psychological,
social, and spiritual) in women survivors of breast cancer who are in the extended or permanent survival
stage.
Data Sources: Systematic review—Four databases were searched: PubMed, CINAHL, PsycINFO, and Web of
Science.
Conclusion: The clinical evidence shows a positive relationship or association between eHealth use and
improved quality of life in breast cancer survivors at extended or permanent survival stage. However, the
findings point to a deficit in the assessment of the social and spiritual domains that play a fundamental role
in the quality of life of survivors.
Implication for Nursing Practice: The findings found reflect implications of great value for nursing practice
because these professionals are the main users of digital health tools to provide them to patients. Using these
digital tools contributes to improving evidence-based practice and providing greater efficiency and effectiveness in the care of long-term cancer survivors., This work was supported by the National Institute of Health Carlos III (ISCIII), Spain, for the period 2022–2024 [grant number PI21/00894]

Background: Long-term cancer survivors have specific needs that are frequently neglected. Telehealth, as a new form of health care, can benefit this growing population.Objective: To identify, analyze, and synthesize the existing evidence on the use of telehealth in the care of cancer survivors after the end of treatment.Methods: A scoping review was conducted in the databases PubMed, CINAHL, COCHRANE, SCIELO, DIALNET, and LILACS and reference institutions in cancer.Results: The initial search yielded 406 publications with 59 articles meeting the eligibility criteria. There are different types of telehealth (video calls, phone calls, websites, mobile applications, and short message services) used for the care of cancer survivors. Most telehealth interventions focus on improving the physical and mental spheres of quality of life in the extended survival phase (from 1 to 3 years postdiagnosis), with only two articles (3%) on long-term cancer survivors (>5 years postdiagnosis). Survivors are satisfied with telehealth interventions, noting the importance of improving comprehensibility, personalization of the platforms, and the lack of excessive information included.Conclusions: Telehealth is a feasible modality for cancer survival care. The scarcity of interventions aimed at long-term survivors stands out, as does the general neglect of the social and spiritual spheres of quality of life.Implications for Practice: Telehealth platforms must adapt their content, format, and items to the preferences reported by the survivors., This review was supported by the National Institute of Health Carlos III (ISCIII), Spain, for the period 2022-2024 (Research projects in health, PI21/00894).

Long-term breast cancer survivors (>5 years free of disease) may suffer late sequelae of cancer that impact on their quality of life. The use of telehealth for cancer care is recommended but little is known about the effectiveness of digital interventions for long-term cancer survivors. This study aims to evaluate the effectiveness of a web-based personalized intervention based on artificial intelligence instead of usual primary health care to improve the quality of life of long-term survivors of breast cancer and self-efficacy for the management of late sequelae. A randomized controlled trial will be conducted. The sample will consist of long-term breast cancer survivors recruited from primary health centers. Women will be randomly assigned to the intervention group to receive a web-based personalized intervention or to the control group to receive standard primary health care by nurses. Data on quality of life of cancer survivors and self-efficacy for the management of late sequelae of cancer will be collected and assessed at preintervention, and at 3, 6, and 9 months. It is expected that, at the end of the programme, the experimental group will have improved quality of life and improved self-efficacy for the management of late sequelae of cancer., This research was funded by National Institute of Health Carlos III (ISCIII), Spain, grant number PI21/00894.